Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 17/2023

06.09.2023 | Research

Development and validation of a predictive model for the diagnosis of bladder tumors using narrow band imaging

verfasst von: Hao Liang, Qingya Yang, Yaozhong Zhang, Hui Sun, Qiang Fu, Tongxiang Diao, Jin Wang, Wei Huang, Yang Xu, Nan Ge, Xuewen Jiang, Shouzhen Chen, Yan Li, Bin Zhou, Peixin Li, Xiaoyi Zhang, Nianzhao Zhang, Benkang Shi, Jun Chen

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 17/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

At present, the prediction of bladder tumor nature during cystoscopy is partially dependent on the clinician's own experience. Subjective factors may lead to excessive biopsy or delayed treatment. The purpose of our study is to establish a reliable model for predicting the nature of bladder tumors using narrow band imaging.

Methods

From November 2021 to November 2022, the clinical data of 231 patients who required a cystoscopy were prospectively collected at our center. Cystoscopy was performed in 219 eligible patients, in which both tumor and vascular morphology characteristics were recorded. Pathological results were used as the diagnostic standard. A logistic regression analysis was used to screen out factors related to tumor pathology. Bootstrap resampling was used for internal validation. A total of 71 patients from four other centers served as an external validation cohort.

Results

The following diagnostic factors were identified: tumor morphology (cauliflower-like or algae-like lesions), vascular morphology (dotted or circumferential vessels), tumor boundary (clear or unclear), and patients’ symptoms (gross hematuria) and were included in the prediction model. The internal validation results showed that the area under the curve was 0.94 (95% CI 0.92–0.97), and the P value from the goodness-of-fit test was 0.97. After external validation, the results showed the area under the curve was 0.89 (95% CI 0.82–0.97) and the P value of the goodness-of-fit test was 0.24.

Conclusion

A diagnostic prediction nomogram was established for bladder cancer. The verification results showed that the prediction model has good prediction performance.
Literatur
Zurück zum Zitat Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A et al (2017) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71(1):96–108CrossRefPubMed Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A et al (2017) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71(1):96–108CrossRefPubMed
Zurück zum Zitat Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid AH et al (2019) European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and Carcinoma In Situ)—2019 update. Eur Urol 76(5):639–657CrossRefPubMed Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid AH et al (2019) European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and Carcinoma In Situ)—2019 update. Eur Urol 76(5):639–657CrossRefPubMed
Zurück zum Zitat Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H et al (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63(2):234–241CrossRefPubMed Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H et al (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63(2):234–241CrossRefPubMed
Zurück zum Zitat Cambier S, Sylvester RJ, Collette L, Gontero P, Brausi MA et al (2016) EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1–3 years of maintenance bacillus calmette-guérin. Eur Urol 69(1):60–69CrossRefPubMed Cambier S, Sylvester RJ, Collette L, Gontero P, Brausi MA et al (2016) EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1–3 years of maintenance bacillus calmette-guérin. Eur Urol 69(1):60–69CrossRefPubMed
Zurück zum Zitat Cauberg ECC, de Bruin DM, Faber DJ, van Leeuwen TG, de la Rosette JJMCH et al (2009) A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications. Eur Urol 56(2):287–296CrossRefPubMed Cauberg ECC, de Bruin DM, Faber DJ, van Leeuwen TG, de la Rosette JJMCH et al (2009) A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications. Eur Urol 56(2):287–296CrossRefPubMed
Zurück zum Zitat Chen H, Hong Y, Yu B, Ruiqian L, Jun L et al (2022) Retrospective analysis of bladder cancer morphology and depth of invasion under cystoscopy. BMC Urol 22(1):12CrossRefPubMedPubMedCentral Chen H, Hong Y, Yu B, Ruiqian L, Jun L et al (2022) Retrospective analysis of bladder cancer morphology and depth of invasion under cystoscopy. BMC Urol 22(1):12CrossRefPubMedPubMedCentral
Zurück zum Zitat Compérat E, Amin MB, Cathomas R, Choudhury A, De Santis M et al (2022) Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet S0140–6736(22):01188–01196 Compérat E, Amin MB, Cathomas R, Choudhury A, De Santis M et al (2022) Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet S0140–6736(22):01188–01196
Zurück zum Zitat Ezoe Y, Muto M, Uedo N, Doyama H, Yao K et al (2011) Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology 141(6):2017-2025.e3CrossRefPubMed Ezoe Y, Muto M, Uedo N, Doyama H, Yao K et al (2011) Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology 141(6):2017-2025.e3CrossRefPubMed
Zurück zum Zitat Herr HW (2010) Narrow-band imaging cystoscopy to evaluate the response to bacille Calmette-Guérin therapy: preliminary results. BJU Int 105(3):314–316CrossRefPubMed Herr HW (2010) Narrow-band imaging cystoscopy to evaluate the response to bacille Calmette-Guérin therapy: preliminary results. BJU Int 105(3):314–316CrossRefPubMed
Zurück zum Zitat Higashi R, Uraoka T, Kato J, Kuwaki K, Ishikawa S et al (2010) Diagnostic accuracy of narrow-band imaging and pit pattern analysis significantly improved for less-experienced endoscopists after an expanded training program. Gastrointest Endosc 72(1):127–135CrossRefPubMed Higashi R, Uraoka T, Kato J, Kuwaki K, Ishikawa S et al (2010) Diagnostic accuracy of narrow-band imaging and pit pattern analysis significantly improved for less-experienced endoscopists after an expanded training program. Gastrointest Endosc 72(1):127–135CrossRefPubMed
Zurück zum Zitat Ikeda A, Nosato H, Kochi Y, Kojima T, Kawai K et al (2020) Support system of cystoscopic diagnosis for bladder cancer based on artificial intelligence. J Endourol 34(3):352–358CrossRefPubMedPubMedCentral Ikeda A, Nosato H, Kochi Y, Kojima T, Kawai K et al (2020) Support system of cystoscopic diagnosis for bladder cancer based on artificial intelligence. J Endourol 34(3):352–358CrossRefPubMedPubMedCentral
Zurück zum Zitat Jeong SH, Han JH, Jeong CW, Kim HH, Kwak C et al (2022) Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor. BMC Cancer 22(1):631CrossRefPubMedPubMedCentral Jeong SH, Han JH, Jeong CW, Kim HH, Kwak C et al (2022) Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor. BMC Cancer 22(1):631CrossRefPubMedPubMedCentral
Zurück zum Zitat Kumar V (2006) A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol-driven haematuria clinic. BJU Int 97(2):301–3055 (discussion 305)CrossRef Kumar V (2006) A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol-driven haematuria clinic. BJU Int 97(2):301–3055 (discussion 305)CrossRef
Zurück zum Zitat Lai LY, Tafuri SM, Ginier EC, Herrel LA, Dahm P et al (2022) Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer. Cochrane Database Syst Rev 4(4):CD014887PubMed Lai LY, Tafuri SM, Ginier EC, Herrel LA, Dahm P et al (2022) Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer. Cochrane Database Syst Rev 4(4):CD014887PubMed
Zurück zum Zitat Lugano R, Ramachandran M, Dimberg A (2020) Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci 77(9):1745–1770CrossRefPubMed Lugano R, Ramachandran M, Dimberg A (2020) Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci 77(9):1745–1770CrossRefPubMed
Zurück zum Zitat Majidpoor J, Mortezaee K (2021) Angiogenesis as a hallmark of solid tumors - clinical perspectives. Cell Oncol (dordr) 44(4):715–737CrossRefPubMed Majidpoor J, Mortezaee K (2021) Angiogenesis as a hallmark of solid tumors - clinical perspectives. Cell Oncol (dordr) 44(4):715–737CrossRefPubMed
Zurück zum Zitat Naito S, Algaba F, Babjuk M, Bryan RT, Sun YH et al (2016) The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in primary non-muscle-invasive bladder cancer patients: trial protocol and 1-year results. Eur Urol 70(3):506–515CrossRefPubMed Naito S, Algaba F, Babjuk M, Bryan RT, Sun YH et al (2016) The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in primary non-muscle-invasive bladder cancer patients: trial protocol and 1-year results. Eur Urol 70(3):506–515CrossRefPubMed
Zurück zum Zitat Naselli A, Introini C, Timossi L, Spina B, Fontana V et al (2012) A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence. Eur Urol 61(5):908–913CrossRefPubMed Naselli A, Introini C, Timossi L, Spina B, Fontana V et al (2012) A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence. Eur Urol 61(5):908–913CrossRefPubMed
Zurück zum Zitat Russo GI, Sholklapper TN, Cocci A, Broggi G, Caltabiano R et al (2021) Performance of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD) Fluorescence Imaging Compared to White Light Cystoscopy (WLC) in detecting non-muscle invasive bladder cancer: a systematic review and lesion-level diagnostic meta-analysis. Cancers (basel) 13(17):4378CrossRefPubMedPubMedCentral Russo GI, Sholklapper TN, Cocci A, Broggi G, Caltabiano R et al (2021) Performance of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD) Fluorescence Imaging Compared to White Light Cystoscopy (WLC) in detecting non-muscle invasive bladder cancer: a systematic review and lesion-level diagnostic meta-analysis. Cancers (basel) 13(17):4378CrossRefPubMedPubMedCentral
Zurück zum Zitat Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M et al (2017) Bladder cancer. Nat Rev Dis Primers 13(3):17022CrossRef Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M et al (2017) Bladder cancer. Nat Rev Dis Primers 13(3):17022CrossRef
Zurück zum Zitat Singer G, Ramakrishnan VM, Rogel U, Schötzau A, Disteldorf D et al (2022) The role of new technologies in the diagnosis and surveillance of non-muscle invasive bladder carcinoma: a prospective, double-blinded, monocentric study of the XPERT© bladder cancer monitor and narrow band imaging© cystoscopy. Cancers (basel) 14(3):618CrossRefPubMed Singer G, Ramakrishnan VM, Rogel U, Schötzau A, Disteldorf D et al (2022) The role of new technologies in the diagnosis and surveillance of non-muscle invasive bladder carcinoma: a prospective, double-blinded, monocentric study of the XPERT© bladder cancer monitor and narrow band imaging© cystoscopy. Cancers (basel) 14(3):618CrossRefPubMed
Zurück zum Zitat Song PH, Cho S, Ko YH (2016) Decision based on narrow band imaging cystoscopy without a referential normal standard rather increases unnecessary biopsy in detection of recurrent bladder urothelial carcinoma early after intravesical instillation. Cancer Res Treat 48(1):273–280CrossRefPubMed Song PH, Cho S, Ko YH (2016) Decision based on narrow band imaging cystoscopy without a referential normal standard rather increases unnecessary biopsy in detection of recurrent bladder urothelial carcinoma early after intravesical instillation. Cancer Res Treat 48(1):273–280CrossRefPubMed
Zurück zum Zitat Tschirdewahn S, Harke NN, Hirner L, Stagge E, Hadaschik B et al (2020) Narrow-band imaging assisted cystoscopy in the follow-up of patients with transitional cell carcinoma of the bladder: a randomized study in comparison with white light cystoscopy. World J Urol 38(6):1509–1515CrossRefPubMed Tschirdewahn S, Harke NN, Hirner L, Stagge E, Hadaschik B et al (2020) Narrow-band imaging assisted cystoscopy in the follow-up of patients with transitional cell carcinoma of the bladder: a randomized study in comparison with white light cystoscopy. World J Urol 38(6):1509–1515CrossRefPubMed
Zurück zum Zitat Yang Q, Liu Z, Sun H, Jiao F, Zhang B, Chen J (2023) A narrative review: narrow-band imaging endoscopic classifications. Quant Imaging Med Surg 13(2):1138–1163CrossRefPubMedPubMedCentral Yang Q, Liu Z, Sun H, Jiao F, Zhang B, Chen J (2023) A narrative review: narrow-band imaging endoscopic classifications. Quant Imaging Med Surg 13(2):1138–1163CrossRefPubMedPubMedCentral
Zurück zum Zitat Zheng C, Lv Y, Zhong Q, Wang R, Jiang Q (2012) Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis. BJU Int 110(1 Pt 1):E680–E687PubMed Zheng C, Lv Y, Zhong Q, Wang R, Jiang Q (2012) Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis. BJU Int 110(1 Pt 1):E680–E687PubMed
Metadaten
Titel
Development and validation of a predictive model for the diagnosis of bladder tumors using narrow band imaging
verfasst von
Hao Liang
Qingya Yang
Yaozhong Zhang
Hui Sun
Qiang Fu
Tongxiang Diao
Jin Wang
Wei Huang
Yang Xu
Nan Ge
Xuewen Jiang
Shouzhen Chen
Yan Li
Bin Zhou
Peixin Li
Xiaoyi Zhang
Nianzhao Zhang
Benkang Shi
Jun Chen
Publikationsdatum
06.09.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 17/2023
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-023-05355-0

Weitere Artikel der Ausgabe 17/2023

Journal of Cancer Research and Clinical Oncology 17/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.